Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Oncology Reports
Published in: Current Oncology Reports 9/2016

01-09-2016 | Head and Neck Cancers (EY Hanna, Section Editor)

Determining Adequate Margins in Head and Neck Cancers: Practice and Continued Challenges

Author: Michelle D. Williams

Published in: Current Oncology Reports | Issue 9/2016

Login to get access

Abstract

Margin assessment remains a critical component of oncologic care for head and neck cancer patients. As an integrated team, both surgeons and pathologists work together to assess margins in these complex patients. Differences in method of margin sampling can impact obtainable information and effect outcomes. Additionally, what distance is an “adequate or clear” margin for patient care continues to be debated. Ultimately, future studies and potentially secondary modalities to augment pathologic assessment of margin assessment (i.e., in situ imaging or molecular assessment) may enhance local control in head and neck cancer patients.
Literature
1.
Looser KG, Shah JP, Strong EW. The significance of “positive” margins in surgically resected epidermoid carcinomas. Head Neck Surg. 1978;1(2):107–11.CrossRefPubMed
2.
Batsakis JG. Surgical excision margins: a pathologist’s perspective. Adv Anat Pathol. 1999;6(3):140–8.CrossRefPubMed
3.
Loree TR, Strong EW. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg. 1990;160(4):410–4.CrossRefPubMed
4.
Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2003;32(1):30–4.CrossRefPubMed
5.•
Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Positive surgical margins in early stage oral cavity cancer: an analysis of 20,602 cases. Otolaryngol Head Neck Surg. 2014;151(6):984–90. This is a national database study highlighting the rate of positive margins between different types of institutions and by anatomic location.CrossRefPubMed
6.
Anderson CR, Sisson K, Moncrieff M. A meta-analysis of margin size and local recurrence in oral squamous cell carcinoma. Oral Oncol. 2015;51(5):464–9. Review.CrossRefPubMed
7.
Yamada S, Kurita H, Shimane T, Kamata T, Uehara S, Tanaka H, et al. Estimation of the width of free margin with a significant impact on local recurrence in surgical resection of oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2016;45(2):147–52.CrossRefPubMed
8.••
NCCN-Principles of surgery-Margins SURG-A page 3 of 9 v1.2015, National Comprehensive Cancer Network Inc. Head and Neck Cancers. This is an oncologic network that develops guidelines and institute standards of care for the treatment of cancer and outcome research. This specific guidance is for the management of Head and Neck Cancers.
9.
Meier JD, Oliver DA, Varvares MA. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck. 2005;27(11):952–8.CrossRefPubMed
10.
Black C, Marotti J, Zarovnaya E, Paydarfar J. Critical evaluation of frozen section margins in head and neck cancer resections. Cancer. 2006;107(12):2792–800.CrossRefPubMed
11.•
Maxwell JH, Thompson LD, Brandwein-Gensler MS, Weiss BG, Canis M, Purgina B, et al. Early oral tongue squamous cell carcinoma: sampling of margins from tumor bed and worse local control. JAMA Otolaryngol Head Neck Surg. 2015;141(12):1104–10. This retrospective study compares methods of tumor margin sampling, from the patient/tumor bed (separately submitted) versus from the en bloc specimen, in stage I/II oral tongue squamous cell carcinomas. The results show that the method of margin sampling effects local control rate.CrossRefPubMed
12.
Chang AM, Kim SW, Duvvuri U, Johnson JT, Myers EN, Ferris RL, et al. Early squamous cell carcinoma of the oral tongue: comparing margins obtained from the glossectomy specimen to margins from the tumor bed. Oral Oncol. 2013;49(11):1077–82.CrossRefPubMed
13.
Woolgar JA, Triantafyllou A. A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens. Oral Oncol. 2005;41(10):1034–43.CrossRefPubMed
14.
Scholl P, Byers RM, Batsakis JG, Wolf P, Santini H. Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue. Prognostic and therapeutic implications. Am J Surg. 1986;152(4):354–60.CrossRefPubMed
15.
Guillemaud JP, Patel RS, Goldstein DP, Higgins KM, Enepekides DJ. Prognostic impact of intraoperative microscopic cut-through on frozen section in oral cavity squamous cell carcinoma. J Otolaryngol Head Neck Surg. 2010;39(4):370–7.PubMed
16.
Patel RS, Goldstein DP, Guillemaud J, Bruch GA, Brown D, Gilbert RW, et al. Impact of positive frozen section microscopic tumor cut-through revised to negative on oral carcinoma control and survival rates. Head Neck. 2010;32(11):1444–51.CrossRefPubMed
17.
Jäckel MC, Ambrosch P, Martin A, Steiner W. Impact of re-resection for inadequate margins on the prognosis of upper aerodigestive tract cancer treated by laser microsurgery. Laryngoscope. 2007;117(2):350–6.CrossRefPubMed
18.
Kerawala CJ, Ong TK. Relocating the site of frozen sections—is there room for improvement? Head Neck. 2001;23(3):230–2.CrossRefPubMed
19.•
Hinni ML, Ferlito A, Brandwein-Gensler MS, Takes RP, Silver CE, Westra WH, et al. Surgical margins in head and neck cancer: a contemporary review. Head Neck. 2013;35(9):1362–70. This is a multifaceted review on surgical margins specifically in head and neck cancers complied by a multidisciplinary group of physicians specializing in the treatment of head and neck cancers.CrossRefPubMed
20.
Dik EA, Willems SM, Ipenburg NA, Adriaansens SO, Rosenberg AJ, van Es RJ. Resection of early oral squamous cell carcinoma with positive or close margins: relevance of adjuvant treatment in relation to local recurrence: margins of 3 mm as safe as 5 mm. Oral Oncol. 2014;50(6):611–5.CrossRefPubMed
21.
Ansarin M, Santoro L, Cattaneo A, Massaro MA, Calabrese L, Giugliano G, et al. Laser surgery for early glottic cancer: impact of margin status on local control and organ preservation. Arch Otolaryngol Head Neck Surg. 2009;135(4):385–90.CrossRefPubMed
22.•
Kwok P, Gleich O, Hübner G, Strutz J. Prognostic importance of “clear versus revised margins” in oral and pharyngeal cancer. Head Neck. 2010;32(11):1479–84. This study evaluates the width of free margin and the impact on local recurrence, showing <5 mm as the threshold altering rate of recurrence in oral cavity T1-T4 tumors (retrospective study).CrossRefPubMed
23.
Weinstein GS, Quon H, Newman HJ, Chalian JA, Malloy K, Lin A, et al. Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. Arch Otolaryngol Head Neck Surg. 2012;138(7):628–34.CrossRefPubMed
24.
Boonstra H, Oosterhuis JW, Oosterhuis AM, Fleuren GJ. Cervical tissue shrinkage by formaldehyde fixation, paraffin wax embedding, section cutting and mounting. Virchows Arch A Pathol Anat Histopathol. 1983;402(2):195–201.CrossRefPubMed
25.
Beaumont DG, Hains JD. Changes in surgical margins in vivo following resection and after fixation. Aust J Otolaryngol. 1992;1:51–2.
26.
Braakhuis BJ, Bloemena E, Leemans CR, Brakenhoff RH. Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue. Oral Oncol. 2010;46(7):485–91.CrossRefPubMed
27.
Bradley PJ, MacLennan K, Brakenhoff RH, Leemans CR. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications. Curr Opin Otolaryngol Head Neck Surg. 2007;15(2):74–81.CrossRefPubMed
28.
Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope. 2002;112(12):2129–40.CrossRefPubMed
29.
van Houten VM, Leemans CR, Kummer JA, Dijkstra J, Kuik DJ, van den Brekel MW, et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer Res : Off J Am Assoc Cancer Res. 2004;10(11):3614–20.CrossRef
30.
van Houten VM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol. 2002;198(4):476–86.CrossRefPubMed
31.
de Carvalho AC, Kowalski LP, Campos AH, Soares FA, Carvalho AL, Vettore AL. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral Oncol. 2012;48(3):240–8.CrossRefPubMed
32.
Bedard N, Schwarz RA, Hu A, Bhattar V, Howe J, Williams MD, et al. Multimodal snapshot spectral imaging for oral cancer diagnostics: a pilot study. Biomed Opt Express. 2013;4(6):938–49.CrossRefPubMedPubMedCentral
33.
Levy LL, Vila PM, Park RW, Schwarz R, Polydorides AD, Teng MS, Gurudutt VV, Genden EM, Miles B, Anandasabapathy S, Gillenwater AM, Richards-Kortum R, Sikora AG. High-resolution optical imaging of benign and malignant mucosa in the upper aerodigestive tract: an atlas for image-guided surgery. ISRN Minim Invasive Surg. 2012;2012.
34.
Keereweer S, Sterenborg HJ, Kerrebijn JD, Van Driel PB, Baatenburg de Jong RJ, Löwik CW. Image-guided surgery in head and neck cancer: current practice and future directions of optical imaging. Head Neck. 2012;34(1):120–6. Review.CrossRefPubMed
35.
Rosbach KJ, Williams MD, Gillenwater AM, Richards-Kortum RR. Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa. Transl Oncol. 2012;5(3):160–71.CrossRefPubMedPubMedCentral
Metadata
Title
Determining Adequate Margins in Head and Neck Cancers: Practice and Continued Challenges
Author
Michelle D. Williams
Publication date
01-09-2016
Publisher
Springer US
Published in
Current Oncology Reports / Issue 9/2016
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-016-0540-y

Other articles of this Issue 9/2016

Current Oncology Reports 9/2016 Go to the issue

Translational Oncology (L Vecchione, Section Editor)

Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer

Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors)

Evolving Immunotherapy Approaches for Renal Cell Carcinoma

Integrative Care (C Lammersfeld, Section Editor)

The Obesity Paradox in Cancer: a Review

Geriatric Oncology (AR MacKenzie, Section Editor)

Exercise Promotion in Geriatric Oncology

Head and Neck Cancers (EY Hanna, Section Editor)

The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma

Sarcomas (SR Patel, Section Editor)

Immunotherapy as a Potential Treatment for Chordoma: a Review
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits